Common Pitfalls in Regulatory Expectations for DCTs—and How to Avoid Compliance Risks
Common Pitfalls in Regulatory Expectations for DCTs—and How to Avoid Compliance Risks Decentralized and hybrid clinical trials (DCTs) have revolutionized the way clinical research is conducted, especially in light of recent global events that necessitate remote patient engagement. However, despite their advantages, DCTs also face unique regulatory expectations that can complicate compliance if not properly…
Read More “Common Pitfalls in Regulatory Expectations for DCTs—and How to Avoid Compliance Risks” »